Aligos Therapeutics(ALGS) - 2020 Q3 - Quarterly Report

Table of Contents Title of each classTrading Symbol(s) Name of each exchange on which registered Common Stock, par value, $0.0001 per share ALGS The Nasdaq Stock Market LLC (Nasdaq Global Select Market) Emerging growth company ☒ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15( ...